Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision entry (v3.6.3) was added to the record history, indicating an update to the study record since the previous version (v3.6.2).SummaryDifference0.1%

- Check25 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The previous revision v3.6.0 was removed from the visible history.SummaryDifference0.1%

- Check39 days agoChange DetectedAdds a recruitment status 'No longer looking for participants' and records the new revision 'Revision: v3.6.0', while removing the older 'Revision: v3.5.5' entry from the history.SummaryDifference0.4%

- Check46 days agoChange DetectedA new revision entry, v3.5.5, was added to the record history, replacing the previous v3.5.4.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the Record History, replacing the previous revision v3.5.3. This indicates an update to the study record and its version history.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page footer’s revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.